Breaking News

Chemic Laboratories and Chemical Solutions Join Forces

February 15, 2016

Collaboration to focus on a variety of pharma and biopharma client interests

Chemic Laboratories (Booth 1460) and Chemical Solutions, after working together for more than five years, have formed a two-year renewable joint cooperation agreement that will enable the two firms to collaborate on a variety of pharmaceutical and biopharmaceutical client interests, primarily in the areas of product development as it pertains to extractables and leachables single-use systems (SUS), pharmaceutical delivery devices and container closure systems.

“Chemic is delighted to expand our working relationship into a formal agreement,” said Joseph St. Laurent, president and chief science officer, Chemic Laboratories. “Chemical Solutions is an established expert in the field of elemental analysis via ICP-MS and is poised to become a leader in the E/L space. This joint agreement allows our two companies to immediately leverage our particular analytical expertise to support our clients growing demand for expert services.”

“By combining Chemic’s experience within the pharmaceutical and biopharmaceutical industries, along with our expertise in trace elemental analysis for the pharmaceutical industry, both Chemic and we are able to offer our respective clients full service analyses for their E&L testing needs,” said Brian LaBine, president, Chemical Solutions.

The cooperation model between the two companies will consist of each company offering each other’s services and direct access to the technical subject matter experts. Chemic and Chemical Solutions will utilize well established and developed chromatographic and spectroscopic analytics to provide extractable and leachable data assessing material compatibility and suitability for pharmaceutical use.

Related Contract Manufacturing:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks